Skip to content
Screener

Allison Transmission Holdings ALSN Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount

Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount at other companies

Allison Transmission Holdings logo
Allison Transmission HoldingsALSN
$0
Diodes logo
DiodesDIOD
$0
Wintrust Financial logo
Wintrust FinancialWTFC
$0-100%
LivaNova logo
LivaNovaLIVN
$0
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$6.1M
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$400K

Other financials

Income statement

See full
Revenue$1.6B+92.4%
Gross profit$515.0M+27.8%
Operating income$291.0M+13.7%
Net income$181.0M-7.2%
EPS (diluted)$2.15-6.1%

Balance sheet

See full
Cash & equivalents$399.0M-48.7%
Total debt$4.2B+75.0%
Total equity$2.0B+12.9%
Total assets$8.7B+61.1%

Cash flow

See full
Operating cash flow$312.0M+69.6%
CapEx$31.0M0.0%
Free cash flow$281.0M+83.7%

Valuation

See full
Market cap$9.6B+30.1%
Enterprise value$13.43B+48.9%
P/E18.2×+8.5×
P/S2.2×-0.1×

Profitability

See full
Gross margin36.4%-12.0pp
Operating margin19.6%-11.7pp
Net margin12%-11.8pp
FCF margin16.7%-3.7pp

Returns & leverage

See full
Return on equity28.3%-18.7pp
Debt / equity2.1×+0.8×
Current ratio1.8×-1.6×

Where this comes from

Reported directly by Allison Transmission Holdings in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The source filing: Allison Transmission Holdings’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:13 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-334039

The Company holds equity securities in unconsolidated entities without a readily determinable fair value. Each of these investments represents a less than 20% ownership interest in the respective privately-held entity, and the Company does not maintain significant influence over or control of any of the entities. The Company has elected the measurement alternative and measures the investments at cost, less any impairment, plus or minus adjustments related to observable price changes in orderly transactions for identical or similar investments of the same issuer. These equity investments are recorded in Other non-current assets in the Condensed Consolidated Balance Sheets, with changes in the value recorded in Other (expense) income, net in the Condensed Consolidated Statements of Comprehensive Income. As of June 30, 2026 and December 31, 2025, the Company held equity securities without a readily determinable fair value of $10 million and $8 million, respectively. During the three and six months ended June 30, 2026, no impairment charges or adjustments resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer occurred for any of these investments.

ITEM 1. Financial Statements

FAQ

What is Allison Transmission Holdings's equity securities without readily determinable fair value impairment loss annual amount?
Allison Transmission Holdings (ALSN) reported equity securities without readily determinable fair value impairment loss annual amount of $0 in Q2 2026.
What does equity securities without readily determinable fair value impairment loss annual amount mean?
Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount as reported by ALLISON TRANSMISSION HOLDINGS, INC..

Ask your AI about Allison Transmission Holdings's equity securities without readily determinable fair value impairment loss annual amount.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude